Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A systematic review of the association between circulating concentrations of C reactive protein and cancer

Identifieur interne : 003A75 ( Main/Exploration ); précédent : 003A74; suivant : 003A76

A systematic review of the association between circulating concentrations of C reactive protein and cancer

Auteurs : Katriina Heikkil [Royaume-Uni] ; Shah Ebrahim [Royaume-Uni] ; Debbie A. Lawlor [Royaume-Uni]

Source :

RBID : ISTEX:3B49EE039F6CDF2F78A9B0D663EC33E1C751009C

English descriptors

Abstract

The objective of this study was to review and summarise the published evidence for an association between circulating concentrations of C reactive protein (CRP) and cancer through a systematic review. 90 discrete studies were identified. 81 (90%) were prevalent case–control or cross-sectional studies, and only 9 studies had a prospective design. In most prevalent studies, CRP concentrations were found to be higher in patients with cancer than in healthy controls or controls with benign conditions. Of the nine large prospective studies identified in this review, four reported no relationship between circulating CRP levels and breast, prostate or colorectal cancers, and five studies found that CRP was associated with colorectal or lung cancers. Most of the studies evaluating CRP as a diagnostic marker of cancer did not present relevant statistical analyses. Furthermore, any association reported in the prevalent studies might reflect reverse causation, survival bias or confounding. The prospective studies provided no strong evidence for a causal role of CRP in cancer. Instead of further prevalent studies, more large prospective studies and CRP gene–cancer association studies would be valuable in investigating the role of CRP in cancer.

Url:
DOI: 10.1136/jech.2006.051292


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A systematic review of the association between circulating concentrations of C reactive protein and cancer</title>
<author>
<name sortKey="Heikkil, Katriina" sort="Heikkil, Katriina" uniqKey="Heikkil K" first="Katriina" last="Heikkil">Katriina Heikkil</name>
</author>
<author>
<name sortKey="Ebrahim, Shah" sort="Ebrahim, Shah" uniqKey="Ebrahim S" first="Shah" last="Ebrahim">Shah Ebrahim</name>
</author>
<author>
<name sortKey="Lawlor, Debbie A" sort="Lawlor, Debbie A" uniqKey="Lawlor D" first="Debbie A" last="Lawlor">Debbie A. Lawlor</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3B49EE039F6CDF2F78A9B0D663EC33E1C751009C</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1136/jech.2006.051292</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-639D29BK-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002151</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002151</idno>
<idno type="wicri:Area/Istex/Curation">002151</idno>
<idno type="wicri:Area/Istex/Checkpoint">001419</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001419</idno>
<idno type="wicri:doubleKey">0143-005X:2007:Heikkil K:a:systematic:review</idno>
<idno type="wicri:Area/Main/Merge">003C30</idno>
<idno type="wicri:Area/Main/Curation">003A75</idno>
<idno type="wicri:Area/Main/Exploration">003A75</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">A systematic review of the association between circulating concentrations of C reactive protein and cancer</title>
<author>
<name sortKey="Heikkil, Katriina" sort="Heikkil, Katriina" uniqKey="Heikkil K" first="Katriina" last="Heikkil">Katriina Heikkil</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Social Medicine, University of Bristol, Bristol</wicri:regionArea>
<wicri:noRegion>Bristol</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ebrahim, Shah" sort="Ebrahim, Shah" uniqKey="Ebrahim S" first="Shah" last="Ebrahim">Shah Ebrahim</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>London School of Hygiene and Tropical Medicine, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lawlor, Debbie A" sort="Lawlor, Debbie A" uniqKey="Lawlor D" first="Debbie A" last="Lawlor">Debbie A. Lawlor</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Social Medicine, University of Bristol, Bristol</wicri:regionArea>
<wicri:noRegion>Bristol</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Epidemiology and Community Health</title>
<title level="j" type="abbrev">J Epidemiol Community Health</title>
<idno type="ISSN">0143-005X</idno>
<idno type="eISSN">1470-2738</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd</publisher>
<date type="published" when="2007-09">2007-09</date>
<biblScope unit="volume">61</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="824">824</biblScope>
</imprint>
<idno type="ISSN">0143-005X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0143-005X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>CRP, C reactive protein</term>
<term>IL, interleukin</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acute phase proteins</term>
<term>Acute phase reactants</term>
<term>Acute phase response</term>
<term>Adequate adjustment</term>
<term>Aetiological role</term>
<term>Aetiology</term>
<term>Alexandrakis</term>
<term>Appropriate analyses</term>
<term>Arterioscler thromb vasc biol</term>
<term>Baseline</term>
<term>Benign</term>
<term>Benign conditions</term>
<term>Benign disease</term>
<term>Benign diseases</term>
<term>Biol markers</term>
<term>Body composition study</term>
<term>Body mass</term>
<term>Breast cancer</term>
<term>Cancer</term>
<term>Cancer cases</term>
<term>Cancer epidemiol biomarkers prev</term>
<term>Cancer events</term>
<term>Cancer outcomes</term>
<term>Cancer patients</term>
<term>Cancer type</term>
<term>Carcinoma</term>
<term>Causal role</term>
<term>Cell lung cancer</term>
<term>Cervical cancer</term>
<term>Chronic disease</term>
<term>Chronic disease epidemiology</term>
<term>Chronic disease prevention</term>
<term>Chronic diseases</term>
<term>Chronic inflammation</term>
<term>Clin</term>
<term>Clin cancer</term>
<term>Clin nutr</term>
<term>Clin oncol</term>
<term>Cochrane library</term>
<term>Cohort</term>
<term>Cohort colorectal cancer</term>
<term>Cohort study</term>
<term>Colorectal</term>
<term>Colorectal cancer</term>
<term>Colorectal cancer risk</term>
<term>Colorectal cancers</term>
<term>Community controls</term>
<term>Comparison group</term>
<term>Control group</term>
<term>Coronary heart disease</term>
<term>Creactive protein</term>
<term>Cytokine</term>
<term>Davey smith</term>
<term>Diagnostic accuracy</term>
<term>Diagnostic value</term>
<term>Differential diagnosis</term>
<term>Discrete studies</term>
<term>Disease activity</term>
<term>Early diagnosis</term>
<term>Ebrahim</term>
<term>Effect estimates</term>
<term>Epidemiol</term>
<term>Epidemiol community health</term>
<term>Epidemiology</term>
<term>Erythrocyte sedimentation rate</term>
<term>Family history</term>
<term>First year</term>
<term>Further adjustment</term>
<term>Gastric cancer</term>
<term>Gastrointestinal cancer</term>
<term>Gene variants</term>
<term>General population</term>
<term>Growth factor</term>
<term>Health study</term>
<term>Healthy comparison group</term>
<term>Healthy controls</term>
<term>Healthy people</term>
<term>Heart disease</term>
<term>Heikkila</term>
<term>Heikkila ebrahim</term>
<term>Hemoglobin levels</term>
<term>Hepatocellular carcinoma</term>
<term>Immune response</term>
<term>Immunological parameters</term>
<term>Incident cancer</term>
<term>Incident colorectal cancer</term>
<term>Infectious disease</term>
<term>Infectious disease epidemiology</term>
<term>Infectious diseases</term>
<term>Inflammation</term>
<term>Inflammatory</term>
<term>Inflammatory cytokines</term>
<term>Inflammatory markers</term>
<term>Inflammatory response</term>
<term>Last meal</term>
<term>Lawlor</term>
<term>Lawlor table</term>
<term>Lifestyle factors</term>
<term>Little evidence</term>
<term>Liver cancer</term>
<term>Lung cancer</term>
<term>Lung cancer patients</term>
<term>Lung cancers</term>
<term>Main focus</term>
<term>Male smokers</term>
<term>Malignant</term>
<term>Malignant diseases</term>
<term>Marker</term>
<term>Mcmillan</term>
<term>Mendelian randomisation</term>
<term>Mendelian randomization</term>
<term>Multiple myeloma</term>
<term>Multiple myeloma patients</term>
<term>Myeloma</term>
<term>Neck cancer</term>
<term>Nutr cancer</term>
<term>Oncol</term>
<term>Other diseases</term>
<term>Ovarian cancer</term>
<term>Oxidative stress</term>
<term>Pancreatic</term>
<term>Pancreatic cancer</term>
<term>Participant</term>
<term>Passam</term>
<term>Physical activity</term>
<term>Plasma protein</term>
<term>Positive association</term>
<term>Potential confounders</term>
<term>Prevalent cancer cases</term>
<term>Prevalent studies</term>
<term>Prognostic</term>
<term>Prognostic marker</term>
<term>Prospective cohort study</term>
<term>Prospective studies</term>
<term>Prospective study</term>
<term>Prostate</term>
<term>Prostate cancer</term>
<term>Protein levels</term>
<term>Public health</term>
<term>Public health agency</term>
<term>Quartile</term>
<term>Reactive</term>
<term>Reactive protein</term>
<term>Search terms</term>
<term>Serum levels</term>
<term>Serum protein</term>
<term>Serum proteins</term>
<term>Shah ebrahim</term>
<term>Small number</term>
<term>Smoking status</term>
<term>Social medicine</term>
<term>Soluble receptor</term>
<term>Statistical analyses</term>
<term>Strong evidence</term>
<term>Study design number</term>
<term>Subsequent risk</term>
<term>Supplementary tables</term>
<term>Survival bias</term>
<term>Systematic review</term>
<term>Testicular cancer</term>
<term>Tobacco smoking</term>
<term>Trend colon</term>
<term>Tumor marker</term>
<term>Tumour</term>
<term>Various cancers</term>
<term>Various locations</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The objective of this study was to review and summarise the published evidence for an association between circulating concentrations of C reactive protein (CRP) and cancer through a systematic review. 90 discrete studies were identified. 81 (90%) were prevalent case–control or cross-sectional studies, and only 9 studies had a prospective design. In most prevalent studies, CRP concentrations were found to be higher in patients with cancer than in healthy controls or controls with benign conditions. Of the nine large prospective studies identified in this review, four reported no relationship between circulating CRP levels and breast, prostate or colorectal cancers, and five studies found that CRP was associated with colorectal or lung cancers. Most of the studies evaluating CRP as a diagnostic marker of cancer did not present relevant statistical analyses. Furthermore, any association reported in the prevalent studies might reflect reverse causation, survival bias or confounding. The prospective studies provided no strong evidence for a causal role of CRP in cancer. Instead of further prevalent studies, more large prospective studies and CRP gene–cancer association studies would be valuable in investigating the role of CRP in cancer.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement>
<li>Londres</li>
</settlement>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Heikkil, Katriina" sort="Heikkil, Katriina" uniqKey="Heikkil K" first="Katriina" last="Heikkil">Katriina Heikkil</name>
</noRegion>
<name sortKey="Ebrahim, Shah" sort="Ebrahim, Shah" uniqKey="Ebrahim S" first="Shah" last="Ebrahim">Shah Ebrahim</name>
<name sortKey="Lawlor, Debbie A" sort="Lawlor, Debbie A" uniqKey="Lawlor D" first="Debbie A" last="Lawlor">Debbie A. Lawlor</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A75 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A75 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:3B49EE039F6CDF2F78A9B0D663EC33E1C751009C
   |texte=   A systematic review of the association between circulating concentrations of C reactive protein and cancer
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021